We found 145 records for "Licensing / acquisition"

Articles

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

UCB looks ahead to next phase

2nd June 2014

 UCB looks ahead to next phaseArticles

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.Ten...

Read more

News

Antibiotics back in vogue as Merck cuts $9.5 billion deal for Cubist

9th December 2014

 Antibiotics back in vogue as Merck cuts $9.5 billion deal for CubistNews

Merck & Co has offered a hefty $9.5 billion to take control of US biotech Cubist Pharmaceuticals, in another signal that big pharma's interest in antibiotics research is returning.   Merck is...

Read more

BioMarin offers $840m for muscular dystrophy firm Prosensa

25th November 2014

 BioMarin offers $840m for muscular dystrophy firm ProsensaNews

Rare disease specialist BioMarin has agreed to acquire Prosensa and its Duchenne muscular dystrophy (DMD) candidate drisapersen in a deal valued at up to around $840 million. The US company...

Read more

Pfizer-Merck cancer deal reduces likelihood of AZ merger

18th November 2014

 Pfizer-Merck cancer deal reduces likelihood of AZ mergerNews

Pfizer has announced an agreement with Merck to co-develop a novel anti-PD-L1 antibody for various cancers.Merck will receive an initial payment of $850 million, with further payments of up to...

Read more

Dendreon files for bankruptcy as Provenge falters

11th November 2014

 Dendreon files for bankruptcy as Provenge faltersNews

Despite its best efforts to streamline and transform itself into a good buy for prospective purchasers, biotech Dendreon has had no offers and has had to file for Chapter 11...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Next steps for NICE: integration, medicine pricing and value based assessments

15th January 2015

Next steps for NICE: integration, medicine pricing and value based assessments

Delegates at the 2015 annual Westminster Health Forum seminar on next steps for NICE are expected to assess the challenges and opportunities facing NICE, priorities for the year ahead and...

Read more

9th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

1st March 2015 - 3rd March 2015

9th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge...

Read more

BioPharma Asia Convention 2015

23rd March 2015 - 25th March 2015

BioPharma Asia Convention 2015

Asia’s biopharmaceutical industry is entering a period of opportunity; the need for industrial collaborations to foster innovation and change has never been more important. The 8th BioPharma Asia Convention is...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more